Part I Overview We are a novel ablation company committed to health innovation using our patented Nano-pulse Stimulation (NPS) technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to nonthermally clear or kill targeted cells. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation (nsPFA) technology when used to ablate cellular tissue, can be used to treat a variety of medical conditio...
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-19 | 2025-12-31 | 0001437749-26-004724 | EDGAR | 58K words |
| 2025-03-31 | 2024-12-31 | 0001437749-25-009932 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001437749-24-009815 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001437749-23-008846 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001625101-22-000016 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001625101-21-000014 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001625101-20-000011 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001625101-19-000008 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001625101-18-000012 | EDGAR | — |
| 2017-03-20 | 2016-12-31 | 0001625101-17-000011 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001437749-25-033354 | EDGAR | 44K words |
| 2025-08-12 | 2025-06-30 | 0001437749-25-026209 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001437749-25-015565 | EDGAR | — |
| 2024-10-30 | 2024-09-30 | 0001437749-24-032614 | EDGAR | — |
| 2024-08-19 | 2024-06-30 | 0001437749-24-027213 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001437749-24-015092 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001437749-23-031686 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001437749-23-023081 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001437749-23-013952 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001625101-22-000067 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001625101-22-000061 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001625101-22-000033 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-27 | 0001437749-26-010105 | EDGAR | 1K words |
| 2026-03-17 | 0001437749-26-008511 | EDGAR | — |
| 2026-03-12 | 0001437749-26-007839 | EDGAR | — |
| 2026-03-09 | 0001437749-26-007283 | EDGAR | — |
| 2026-03-03 | 0001437749-26-006629 | EDGAR | — |
| 2026-02-27 | 0001437749-26-006141 | EDGAR | — |
| 2026-02-19 | 0001437749-26-004739 | EDGAR | — |
| 2026-02-19 | 0001437749-26-004726 | EDGAR | — |
| 2026-02-06 | 0001437749-26-003256 | EDGAR | — |
| 2026-01-14 | 0001437749-26-001225 | EDGAR | — |
242 total filings indexed. 210 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001625101 |
| Ticker | PLSE |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.pulsebiosciences.com |
| Listed | 2016-05-18 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report